Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis

被引:0
|
作者
Kenyon, Sarrinder [1 ]
Careless, David [2 ,3 ]
Navaratnam, Vidya [4 ,5 ]
Reddy, Taryn [1 ,6 ]
机构
[1] Prince Charles Hosp, Dept Med Imaging, Chermside, Qld 4032, Australia
[2] St Andrews Ipswich Private Hosp, Dept Gen Med, Ipswich, Qld, Australia
[3] Ipswich Hosp, Dept Gen Med, Ipswich, Qld, Australia
[4] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia
[5] Curtin Univ, Div Hlth Sci, Perth, WA, Australia
[6] Univ Queensland, Fac Med, Herston, Qld, Australia
关键词
Connective tissue disease associated lung disease;
D O I
10.1136/thorax-2022-219859
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:946 / 947
页数:2
相关论文
共 50 条
  • [31] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [32] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Huyan Wang
    Xin Chen
    Yan Du
    Lihua Wang
    Qiyuan Wang
    Huaxiang Wu
    Lei Liu
    Jing Xue
    Arthritis Research & Therapy, 25
  • [33] Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti-MDA5 antibody titer in two cases
    Awaji, Kentaro
    Asano, Yoshihide
    Fukui, Yuki
    Oka, Tomonori
    Toyama, Tetsuo
    Sato, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 78 - 81
  • [34] A Fatal Case of Anti-MDA5 Antibody Positive Clinically Amyopathic Dermatomyositis (CADM) Associated with Rapidly Progressive Interstitial Lung Disease
    Mohammed, A.
    Torres, C.
    AlNabulsi, M.
    Smith, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] Janus kinase inhibition in induction treatment of anti-MDA5 juvenile dermatomyositis-associated rapidly progressive interstitial lung disease
    Chan Ng, Poh Lin Pauline
    Mopur, Archana
    Goh, Daniel Yam Thiam
    Ramamurthy, Mahesh Babu
    Lim, Michael Teik Chung
    Lim, Lee Kean
    Ooi, Pei Ling
    Ang, Elizabeth Youning
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (02) : 228 - 231
  • [36] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5-RELATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS
    Cardenas, Carlos
    Gupta, Surbhi
    Kim, Jaehyun
    Kershaw, Corey
    Tomlinson, Andrew
    CHEST, 2019, 156 (04) : 1867A - 1868A
  • [37] Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review
    Takanashi, Satoshi
    Kaneko, Yuko
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 231 - 237
  • [38] Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis
    Nandy, A.
    Gaini, S.
    Sore, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 334 - 335
  • [39] Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease
    Biddle, Kathryn
    Agaoglu, Elif
    Brent, Geoffrey
    Adam, John
    Nockels, Rachel
    Loveridge, Adam
    Bazari, Farid
    Natkunarajah, Janakan
    Al-Shakarchi, Israa
    OXFORD MEDICAL CASE REPORTS, 2024, 2024 (06): : 249 - 254
  • [40] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ASSOCIATION WITH MDA5 ANTIBODY DERMATOMYOSITIS
    Kazmierski, Dan
    Sharma, Nishant
    Wang, Yichen
    Noumi, Bassel
    Ochieng, Pius
    Ejaz, Komal
    CHEST, 2020, 158 (04) : 1140A - 1141A